Introduction {#S1}
============

The major aim of stroke therapies is to stimulate brain repair and to improve behavioral recuperation after cerebral ischemia. However, in animal models, brain tissue replacement does not occur after focal ischemia stimulating the search for alternative strategies for brain repair and behavioral recuperation after stroke. One strategy is to stimulate the endogenous brain repair and functional recovery following ischemic insult ([@B26]). Following stroke injury in striatum, in neurogenic regions (hippocampus and subventricular zone, SVZ), vigorous neurogenesis is initiated both in young and aged animals ([@B4]). Furthermore, the newly born cells were shown to be able to migrate from the SVZ to the stroke-damaged striatum, develop and differentiate into the phenotype of the neurons damaged by ischemic lesion ([@B4]; [@B62]). However, later is has been shown that migration of SVZ-neuroblasts to the nearby striatum and corpus callosum was valid only for the 2 months old mice ([@B2]). Furthermore, for focal cortical stroke, the migration of neuronal precursors from the SVZ to the peri-infarcted area does occur to a lesser extent ([@B54]).

During aging, the potential of the hippocampus and the SVZ to generate new neuronal precursors declines, but the cause of this decline is not precisely known ([@B16]). Most likely, aging reduces the neurogenic potential by disrupting the intricate cellular organization of the SVZ ([@B15]). Interestingly, while neuronal cells production declines with increasing age, the generation of oligodendroglia is not altered ([@B15]).

The production of new cells in neurogenic regions can be modulated by physical activity, enriched environment, or epileptic drugs ([@B14]; [@B29]). It is also known that abnormal brain electrical activity results in a robust increase in the number of neuronal precursors in the adult hippocampus and subventricular zone ([@B40]). However, in remote areas such as the cortex, few of the new born cells will survive and their contribution of the survived cells to neurological recovery is questionable. Therefore, we hypothesized that stimulating neurogenesis in the subventricular zone and hippocampus after the neuroinflammation has diminished ([@B5]; [@B28]; [@B52]), would increase the odds of behavioral recovery. Given the maturation period of neuronal precursors in the hippocampus and subventricular zone of 24 days ([@B14]), we stimulated neurogenesis by electrical stimulation (ES) at 7 and 24 days after stroke and assessed behavioral recuperation and molecular and cellular indices of post-stroke recovery of the brain in aged rats.

Materials and Methods {#S2}
=====================

In this study we used aged male Sprague-Dawley rats (*N* = 56; 18--20 months of age; 520--600 g) kept under standard condition of temperature and humidity in the Animal House Facility with free access to food and water. The group sizes for the aged rats were larger to compensate for the post-ischemic mortality rate which was of 15%, except sham-operated rats. The control and treatment groups consisted of *N* = 18 age-matched animals. The number of sham-operated rats was of *N* = 20. All experiments were performed in accordance with "ARRIVE Guidelines for the Care and Use of Laboratory Animals," and animal procedures were approved by the Animal Experimentation Ethics Board of the State of Mecklenburg-Vorpommern as meeting the ethical requirements of the German National Act on the Use of Experimental Animals (approval no LALLF M-V/TSD/7221.3-1.1- 040/10) and by the Institutional Animal Care and Use Committee of the Medical University of Craiova (\# 87-15-11-2017).

Randomization {#S2.SS1}
-------------

Random assignment was done for (i) group assignment, (ii) surgery assignment; and (iii) treatment assignment.

Behavioral Testing {#S2.SS2}
------------------

Testing procedure involved two persons, one person who did the surgery and was in charge of handling the animals according to group assignment and another one who has tested the animals and was not aware of groups' identity. To evaluate changes in neurological function associated with ischemia, the rats were subjected to a variety of somatosensory, motor, learning, and memory tests before and after surgery. All testing was performed from 9 to 11 a.m. Results obtained before surgery were used to define 100% functionality for each animal on each test, and functional recovery was expressed either as SCORE or as percent recovery relative to the pre-surgery baseline.

### Rotating Pole {#S2.SS2.SSS1}

The rotating pole task assesses coordination and sensorimotor function in the MCAO model. Each rat was tested for its ability to cross a rotating (6 rpm) horizontal rod. The score assessment was done as previously described by our group ([@B12]). Briefly, the time taken for the rat to traverse the rotating pole and join a group of rats visible at the finish line was measured. The score assessment was twofold: (i) time (seconds) required to tra- verse the rotating pole and (ii) the score as follows: 0 -- rat falls immediately (onto a soft surface); 1 -- rat does not walk forward, but stays on the rotarod; 2 -- rat walks, but falls before reaching the goal; 3 -- rat traverses the rod successfully, but the limbs are used asymmetrically; 4 -- the left hindlimb is used less than 50% of the time taken to traverse the rod; 5 -- the rat successfully traverses the rod, but with some difficulties; 6 -- no mistakes, symmetric movements.

### Asymmetric Sensorimotor Deficit: Adhesive Tape Removal Test {#S2.SS2.SSS2}

We assessed the asymmetry of sensorimotor deficit of the forelimbs induced by unilateral MCAO by the adhesive tape removal test. In short, sticky patches were applied on the distal hairless parts of the forelimbs and the removal time from both limbs was measured. Three trials were done separately for each limb and the means of the values were noted. If the animal did not remove the tape within 180 s, the timer was stopped. Results are given as time needed to remove the adhesive tape from one forelimb divided by the sum of time needed to remove it from both forelimbs ([@B46]).

### Inclined Plane {#S2.SS2.SSS3}

We tested the ability of each animal to maintain its position at a given angle on an inclined plane ([@B12]). The relative angle at which the rat could no longer maintain its position was taken as a measure of functional impairment. This test was conducted once before surgery and daily thereafter.

### Spatial Long-Term Memory: T-Maze {#S2.SS2.SSS4}

T-maze was chosen to assess retention of memory on positive reinforcement as previously described ([@B37]). Rats were trained for 2 weeks before MCAO surgery to find food in a maze of three consecutive junctions. We scored every error with one point, therefore a successful trial was scored as 0 and the maximum number of allowed mistakes was 3. Because the apparatus was made up of 3 T-mazes, the rats could commit 1, 2, or 3 errors in each trial. On the surgery day, an average of the last three performances was calculated and was considered as baseline.

Surgery {#S2.SS3}
-------

Prior surgery rats were fasted overnight to reduce the blood glucose levels. After craniotomy the middle cerebral artery (MCA) was exposed and slowly lifted with a tungsten hook attached to a micromanipulator (Maerzhaeuser Precision Micro-manipulator Systems, Fine Science Tools) and electrocoagulated. Both common carotid arteries were then occluded by tightening pre-positioned thread loops for 90 min. Throughout surgery, anesthesia was maintained by spontaneous inhalation of 1--1.5% isoflurane in a mixture of 75% nitrous oxide and 25% oxygen. Body temperature was controlled at 37°C by a Homeothermic Blanket System (Harvard Apparatus). The local changes in blood flow were monitored using a laser Doppler device (Perimed, Stockholm, Sweden), and blood gasses were measured at several time points during ischemia. A decrease in laser Doppler signals to \<20% of control values was considered to be successful MCA occlusion. The surgical procedure for the sham group was identical, except for the MCA electrocoagulation.

After 90 min, the common carotid arteries were re-opened. The muscle and soft tissue were replaced and the skin was closed using 5-0 nylon suture. Buprenorphine was given sc twice, every 6 h after surgery at a dose of 0.3 mg/kg for peri-operative pain relief. Moisted food was provided for the first 3 days post-surgery.

Subsequent to survival time of 48 days, the rats were deeply anesthetized with 2.5% isoflurane in 75% nitrous oxide and 25% oxygen, and perfused with neutral buffered saline followed by buffered 4% freshly depolymerized paraformaldehyde. The brain was removed, post-fixed in 4% buffered paraformaldehyde for 24 h, cryoprotected in 15% glycerol prepared in 10 mmol/l phosphate buffered saline, flash-frozen in isopentane and stored at −70°C until sectioning.

Stimulation of Endogenous Neurogenesis by Non-convulsive Electrostimulation {#S2.SS4}
---------------------------------------------------------------------------

At 7- and 24 days after stroke, animals were stimulated by the application of ear-clip electrodes. Ear-clip electrodes were moistured with saline and attached to the pinnae. Endogenous neurogenesis in aged rats was stimulated by a subconvulsive train (30 mA, 60 pulses/sec, 0.5-ms pulse width, 1-s duration and in total for 5-s) ([@B59]).

The ES treatment was done under mild anesthesia (ketamine 85 mg/kg, PromAce 0.85 mg/kg).

BrdU Labeling {#S2.SS5}
-------------

To label newly generated cells, rats were given injections of bromodeoxyuridine (BrdU; 50 mg/kg body weight, i.p.; Sigma) immediately after the stimulation followed by two more injections in the next 2 days.

Immunohistochemistry {#S2.SS6}
--------------------

Sections (25 μm-thick) were cut on a freezing microtome and processed for immunohistochemistry as previously described ([@B45], [@B46]). For DAB staining, sections were blocked in 3% donkey serum/10 mmol/l PBS/0.3% Tween 20, overnight at 4°C. Secondary biotinylated antibodies were raised in the donkey (Jackson ImmunoResearch Laboratories, West Grove, PA, United States). Sections were stained using the ABC Elite reagents (Vectastain Elite Kit, Vector) using 0.025% 3′,3′ diaminobenzidine (DAB) and 0.005% hydrogen peroxide as the chromogen. For BrdU detection by diaminobenzidine- (DAB) staining, free-floating sections were pre-treated with 50% formamide, 0.3 M NaCl, 10 mM sodium citrate at 65°C for 2 h, incubated in 2 M HCl at 40°C for 1 h, and rinsed in 0.1 M borate buffer (pH 8.5) at room temperature for 10 min. Sections were incubated with the rat anti-BrdU (1:2000, Serotec, United Kingdom) at 4°C for 24 h. BrdU-positive nuclei were visualized using goat anti-rat-Cy5. For phenotyping, the tissue was incubated with a rabbit anti-NeuN (1:1000, Novus Biologicals, United Kingdom) and guinea pig anti-doublecortin (1:2000; Millipore, Germany) at 4°C overnight. At the next day, sections were rinsed with PBS and incubated with Alexa Fluor^®^ 568 goat anti-rabbit IgG and Alexa Fluor^®^ 488 goat anti-guinea pig IgG. Neuronal cells expressing Tubulin beta III, sections were incubated with rabbit anti-tubulin beta III (1:5000; Abcam, United Kingdom).

Counting of Co-localized DCX/BrdU- and Tubulin Beta III/BrdU Positive Cells {#S2.SS7}
---------------------------------------------------------------------------

Double labeled cells were analyzed in every 10th section in the region adjacent to the scar-confined area corresponding to the formerly infarct core, hippocampus and subventricular zone as previously described ([@B46]). To this end, a sequence of confocal counting images of 161 μm × 242 μm × 25 μm, spaced 0.1 μm apart across a 25 μm-thick section and covering 30% of the infarcted area, was taken for fluorescently labeled cells ([@B45]). The relative mean number of double labeled cells was then calculated by multiplying the number of cells per section times 3.3 (the counting boxes that were quantitated covered one third of the area of each section) times the section interval of 10. By using this approach we were able to overcome the difficulty of cell counting in both dentate gyrus and SVZ which are extremely heavily packed with cells ([@B1]).

Determination of Infarct Volume by MRI {#S2.SS8}
--------------------------------------

Magnetic resonance imaging (MRI) was used to visualize the infarct volume for both groups at day 48 after stroke. MRI measurements were performed on a 7-T Bruker ClinScan magnet with a 20 cm inner bore, capable of 290 mT/m in 250 μs (Bruker BioSpin MRI, Ettlingen, Germany) ([@B27]). Images were received by a 2 × 2 phased array RF coil, designed specifically for rat brain studies that was placed directly on the skull. The animals were anesthetized during imaging to minimize discomfort. Respiratory rate was monitored, and isoflurane concentrations were varied between 1.5 and 2.0% to keep the respiratory rate between 35 and 45/min. After positioning the animal's head, T2-weighted MRI was recorded were performed with a multislice spin-echo sequence with 25 slices of 0.7 mm thickness and a matrix size 640 pixels × 640 pixels, field-of-view of 32 mm × 32 mm, a repetition time (TR) of 4,330 ms, and an echo time (TE) of 45 ms.

Lesion Measurement Using MIPAV Software {#S2.SS9}
---------------------------------------

T2WI lesion volumes were determined using the image processing software Medical Image Processing, Analysis and Visualization (MIPAV, version 3.0, National Institutes of Health, Bethesda, MD, United States). After optimal adjustment of contrast, the edge of the lesion was traced manually on each of the 25 coronal slices, which completely covered the MCA territory in all animals. The areas of hyperintensity were then summed and multiplied by the slice thickness to calculate lesion volumes as previously described ([@B27]).

Transcriptomic Analysis {#S2.SS10}
-----------------------

### RNA Extraction and RNA Quality Control {#S2.SS10.SSS1}

After the tissue was homogenized, total RNA was extracted from microdissected tissue using TRIzol reagent (Invitrogen Life Technologies, Karlsruhe, Germany). Genomic DNA was removed using the RNeasy Plus kit (Qiagen).

### Microarray Hybridization {#S2.SS10.SSS2}

Prior to sample preprocessing, RNA integrity of RNA pools was assessed with the RNA 6000 nano kit using the Bioanalyzer 2100 instrument (Agilent, Böblingen, Germany). RNA integrity numbers ranged between 6.5 and 8.2. 200 ng of each sample were processed with the whole transcript (WT) expression kit (Ambion, Darmstadt, Germany), i.e., subjected to RNA amplification via reverse transcription to double-stranded cDNA and subsequent *in vitro* transcription; this was followed by another round of reverse transcription yielding single-stranded DNA in sense orientation. Hybridization cocktails were produced after fragmentation and biotin labeling of target DNAs following the protocol of the GeneChip WT terminal labeling kit (Affymetrix, Santa Clara, CA, United States). Microarray hybridization to GeneChip Rat Gene 2.0 ST arrays (Affymetrix) was performed according to the manufacturer's protocol using the Fluidics Station 450 with the program FS450_0007. CEL files from scanned microarrays were produced with the expression console (Affymetrix).

### Microarray Evaluation {#S2.SS10.SSS3}

Consistently high quality microarray data was ensured by visual inspection of scanned images for hybridization artifacts and correspondence analysis of raw and normalized microarray data. Normalizations were performed with the Quantiles method; background correction and probe set summary were achieved with Robust Microarray Average (RMA) as previously described ([@B13]). Differentially expressed genes were determined for ECS vs. sham and stroke controls vs. sham operated aged rats comparisons. The False Discovery Rate (FDR) of differential expression for the described comparisons was estimated with an empirical Bayes methodology employing lognormal normal data modeling. All analyses were performed in R version 2.14.0^[1](#footnote1){ref-type="fn"}^ along with Bioconductor^[2](#footnote2){ref-type="fn"}^ packages affy, EBarrays, and made4. Principle component analysis (PCA) and agglomerative hierarchical clustering (AHC) were carried out using the Rosetta Resolver Data Reduction and the 2D Cluster wizards.

### Quantitative Real-Time PCR {#S2.SS10.SSS4}

For quantitative real time PCR (qPCR), we synthesized cDNA from large pools (*n* = 19--24) of total RNA with the High-Capacity cDNA reverse transcription kit (Applied Biosystems, United States). The qPCR was performed in 96-well 0.1-ml thin-wall PCR plates (Applied Biosystems) in the Step One Plus System (Applied Biosystems). Each 20 μl reaction contained 10 μl iQ SYBR Green Master Mix (Bio-Rad Laboratories, Hercules, CA, United States), 2 μl gene-specific forward and reverse primer mix (Qiagen, Alameda, CA, United States) and 8 μl pre-diluted cDNA. No template controls contained nuclease-free water instead. The cycling conditions were 3 min 95°C to activate iTaq DNA polymerase followed by 45 cycles with 30 s denaturation at 95°C, 30 s annealing at 58°C and 30 s elongation at 72°C. At the end of the amplification cycles, melting curves were used to validate PCR product specificity. All samples were amplified in triplicate. Data were analyzed using the ΔΔ*C*t method \[24\]. The expression levels of genes of interest were normalized to the average of expression level of the three housekeeping genes (GAPDH, HPRT1 and Ribosomal protein 19, RPL 19) from the same sample. The fold change for a gene of interest was defined as the ratio of the relative expression in the ipsilateral hemisphere (stroke lesioned, peri-infarcted or PI) to that in the sham-operated animals. All primers were provided by Eurofins, Germany.

Statistical Analysis {#S2.SS11}
--------------------

The main effects of time and treatment for behavioral testing were evaluated by 2 way ANOVA followed by Dunnett's multiple comparisons test using GraphPad software. For the analysis of histological data, we used one-way ANOVA followed by Dunnett's multiple comparisons test for assessing the effect of treatment on the number of (i) DCX-positive cells in the hippocampus; (ii) co-localized DCX/BrdU cells in the subventricular zone and, (iii) the number of TUB/BrdU co-localized cells in the infarct core and peri-infarcted area using GraphPad software. The level of significance was set at *p* ≤ 0.05.

Results {#S3}
=======

The experimental design is shown in [Figure 1](#F1){ref-type="fig"}, upper panel. For the first 3 days after the stroke, animals in all groups were fed soft pellets to facilitate nutrition. Thereafter they were permitted to eat *ad libitum.* The mortality rate was almost identical, 18% for each group, except sham-operated animals. All animals died in the first 10 days after stroke.

![**(Upper)**: experimental design. Before surgery, rats were subjected to a variety of somatosensory, motor, learning, and memory tests (training and baseline). At 7- and 24 days after stroke, animals were stimulated by the application of ear-clip electrodes. Subsequent to survival time of 48 days, rats were subjected to MRI and the brains analyzed by immunohistochemistry. **(Lower)**: behavioral testing. There was a drop in performance shortly after the operation, part of which could be attributed to surgical stress and aging. The aged rats started recovery after a delay of 3--6 days, depending on task difficulty. Electrical stimulation had a significant beneficial effect on spatial long-term memory \*\*\**P* = 0.0001 by 2-way ANOVA followed by Dunnett's multiple comparisons test **(C)**. However, there was no beneficial effect of ES on complex sensorimotor skills like the rotating pool **(A)** or inclined plane **(B)**. Surprisingly, ES had a detrimental effect on the asymmetric sensorimotor deficit **(D)**. \*\*\**P* = 0.0001 by 2-way ANOVA followed by Dunnett's multiple comparisons test. Error bars indicate S.E.M.](fnins-14-00732-g001){#F1}

Behavior {#S3.SS1}
--------

### The Rotating Pole Task {#S3.SS1.SSS1}

Craniotomy in aged rats is stressful and impacts on functional recovery, especially for tests which require complex sensorimotor skills. For this reason, all animals, except the sham-operated controls, had difficulty mitigating the rotating pole in the first 3 days post-stroke. After a further decline in performance of electrically stimulated animals during the first week post-stroke, the ischemic aged rats began improvement and recovered to the pre-stroke levels by day 48 ([Figure 1A](#F1){ref-type="fig"}). There was, however, no significant improvement in the ES group as compared to the control group.

### Inclined Plane {#S3.SS1.SSS2}

Inclined plane test was used to assess complex motor and balance behavior after stroke. In aged rats, stroke severely impaired performance on the inclined plane test, and both the ES and control aged rats recovered to a limited extent during the study period ([Figure 1B](#F1){ref-type="fig"}). Electric stimulation was not effective throughout the study period, and did not stimulate aged rats to recover any better than controls ([Table 1](#T1){ref-type="table"}). Recovery of sham-operated rats was complete shortly after stroke ([Figure 1B](#F1){ref-type="fig"}).

###### 

Analysis of differentially regulated genes.

  **Sequence code**                                                                        **Gene name**   **Sequence description**                           **Function**                            **ES/CTRL**   ***P*-value**
  ---------------------------------------------------------------------------------------- --------------- -------------------------------------------------- --------------------------------------- ------------- ---------------
  **Unique to ECS stimulation**                                                                                                                                                                                     
  1397833_at                                                                               LOC304554       Seizure related 6 homolog like                     Seizure related                         5,37          0,03
  1386881_at                                                                               Igfbp3          Insulin-like growth factor binding protein 3       Neuroprotective                         5,06          \<0,001
  1384218_at                                                                               LOC362795       Immunoglobulin G heavy chain                       Chronic focal encephalitis              3,60          \<0,001
  1390835_at                                                                               Slc47a1         Solute carrier family 47 member 1                  Brain microvessel endothelial cells     2,79          0,01
  **Synergistic upregulation (upregulated both by stroke and electric stimulation)**                                                                                                                                
  1388181_at                                                                               LOC641523       Immunoglobulin delta heavy chain constant region   B cell development; unknown to stroke   11,05         \<0,001
  1370967_at                                                                               Cdc37           Cell division cycle protein 37                     Neurogenesis, axon guidance             5,83          \<0,001
  1398657_at                                                                               LOC502834       Ig kappa chain V--III region MOPC 63-like          Restless legs syndrome                  5,79          \<0,001
  1388272_at                                                                               Igh-1a          Immunoglobulin heavy constant gamma 2A             B cell development; unknown to stroke   4,48          \<0,001
  1374334_at                                                                               Igha            Immunoglobulin heavy constant alpha                B cell development; unknown to stroke   3,62          \<0,001
  1395126_at                                                                               Fcrls           Fc receptor-like S scavenger receptor              Neurodegenerative diseases              3,55          \<0,001
  1383163_at                                                                               Igj             Immunoglobulin J polypeptide                       Ataxia teleangiectatica                 3,13          \<0,001
  1385813_at                                                                               RGD1310251      Marginal zone B and B1 cell-specific protein       Sjogren's syndrome                      3,31          \<0,001
  1370394_at                                                                               IgG-2a          Gamma-2a immunoglobulin heavy chain                Development of Schizophrenia            2,37          \<0,001
  **Synergistic downregulation (downregulated both by stroke and electric stimulation)**                                                                                                                            
  1387680_at                                                                               Pde1b           Phosphodiesterase 1B, calmodulin-dependent         Learning and memory                     −11,13        \<0,001
  1391938_at                                                                               Usp11           Ubiquitin specific peptidase 11                    Regulation of apoptosis                 −8,34         0,03
  1368479_at                                                                               Drd1a           Dopamine receptor D1A                              Feeding behavior; depression            −6,70         \<0,001
  1378899_at                                                                               Slc35d3         Solute carrier family 35 member D3                 Autophagy, development                  −6,11         \<0,001
  1370760_at                                                                               Gad1            Glutamate decarboxylase 1                          Neuronal development                    −2,67         0,02
  1395447_at                                                                               Ermn            Ermin                                              Epileptic seizure; multiple sclerosis   −2,84         \<0,001
  1368300_at                                                                               Adora2a         Adenosine A2a receptor                             Neurodegeneration                       −2,34         \<0,001
  1369309_at                                                                               Tac1            Tachykinin precursor 1                             Pain                                    −2,45         \<0,001

### Spatial Long-Term Memory: T-Maze {#S3.SS1.SSS3}

After training, aged rats learned to finish the T-maze test almost perfectly ([Figure 1C](#F1){ref-type="fig"}). Post-stroke, T-maze performance declined sharply in all groups, including the sham-operated one. Following the second ES, however, there was a significant effect of the treatment \[*F*(2,336) = 83.75, *P* \< 0.0001\], time \[*F*(11,168) = 19.85, *P* \< 0.0001\], and treatment × time interaction \[*F*(22,336) = 4.602, *P* \< 0.0001\] by 2 way ANOVA.

### Asymmetric Sensorimotor Deficit {#S3.SS1.SSS4}

The adhesive tape removal test probes for differences in cutaneous sensitivity and sensorimotor integration of the forelimbs after stroke ([@B6]). As compared to pre-surgery values, post-stroke rats showed a significant decline in performance for the affected forelimb. By day 7, animals in the control group started recovery and reached significant recuperation by day 24 as compared to the ES group which started to recover very late, by day 34 ([Figure 1D](#F1){ref-type="fig"}). More specifically, 2 way ANOVA analysis revealed a significant effect of treatment \[*F*(2,476) = 37.14, *P* \< 0.0001\], time \[*F*(13,238) = 3.847, *P* \< 0.0001\], and treatment × time interaction \[*F*(26,476) = 3.371, *P* \< 0.0001\].

Infarct Volume {#S3.SS2}
--------------

Cortical infarcts as defined by the region of T2 hyperintensity for each group, are shown in [Figure 2](#F2){ref-type="fig"}. Infarct volume was larger in the ECS group ([Figure 2B](#F2){ref-type="fig"}) than in control rats ([Figure 2A](#F2){ref-type="fig"}). However, the difference was not statistically significant (*P* = 0.21; [Figure 2C](#F2){ref-type="fig"}). Noteworthy, at this post-stroke time we did not expect a significant contribution of the brain edema to the infarct volume.

![Effect of the electrical stimulation on infarct size. **(A,B)** On MRI, the ischemic lesion appeared as a hyperintense area on T2-weighted images. In some animals, the infarct volume was larger in the treatment group. However, the infarct volume was not significantly (*P* = 0.21) changed between controls and treated animals **(C)**.](fnins-14-00732-g002){#F2}

ES-Specific Long-Term Down Regulation of Gene Expression in the Perilesional Cortex {#S3.SS3}
-----------------------------------------------------------------------------------

The pattern of gene expression became very dissimilar by day 48 post-stroke. The heatmap shows that relative expression levels clearly distinguished ES rats from the corresponding controls ([Figure 3A](#F3){ref-type="fig"}). The left-hand heatmap of ES animals is clearly divided into two major groups; a large group of transcripts those expression is strongly down regulated as compared to controls and sham-operated animals, and a much smaller group of genes displaying higher expression levels than in those in controls and sham-operated animals. The right-hand heatmap of controls also contains two major groups; one group consists of transcripts those expression is up regulated as compared both to ES- and sham-operated animals. Another group includes gene those expression was lower than in sham-operated animals but higher than in ES animals. Further, in [Figure 3B](#F3){ref-type="fig"}, we can clearly distinguish the effect of ES, shown in the blue box, as compared with the red box for controls and green box for sham-operated animals. The effect of stroke is given as Axis 1, and the effect of the treatment is given as Axis 2.

![ES-specific long-term down regulation of gene expression in the perilesional cortex after stroke. The pattern of gene expression became very dissimilar by day 48 post-stroke. The heatmap shows that relative expression values clearly distinguish ES rats from their post-stroke controls **(A)**. The left-hand heatmap of ES animals subdivides expression levels into two major groups; the larger one consists of those probe sets whose expression is strongly down regulated in post-stroke animals than in controls and sham-operated ones, whereas the smaller group contains transcript clusters with higher expression than in controls and sham-operated ones. Further, we can clearly distinguish the ES effect shown in the blue box as compared with the red box for controls and green box for sham-operated animals. The effect of stroke is given as Axis 1, and the effect of the treatment as Axis 2 **(B)**.](fnins-14-00732-g003){#F3}

Analysis of differentially regulated genes revealed that 4 genes were unique to ES, 9 genes were upregulated both by stroke and ES and 8 genes were downregulated both by stroke and ES. The expression of these genes was confirmed by RT-PCR ([Table 1](#T1){ref-type="table"}).

### Genes Unique to Electrical Stimulation {#S3.SS3.SSS1}

Genes that were upregulated in the perilesional cortex of ES aged rats, included *LOC04554*, *Igfbp3*, *IgG heavy chain* and *solute carrier family 4 member 1*. Remarkably, one of these genes, *seizure related 6 homolog like* is one of the physiological substrate of the β-secretase BACE1 (β-site APP cleaving enzyme), involved in the pathophysiology of Alzheimer's disease and a drug target ([@B43]). The upregulated genes included *insulin-like growth factor-binding protein 3* (*Igfbp3*) a biomarker of transient ischemic attack ([@B41]), *immunoglobulin G heavy chain* involved in chronic focal encephalitis ([@B7]) and *solute carrier family 47 member 1* (*Slc47a1*) expressed in brain microvessel endothelial cells (BMEC) of the blood brain barrier ([@B57]) ([Table 1](#T1){ref-type="table"}).

### Synergistic Upregulated Genes {#S3.SS3.SSS2}

Transcripts that were upregulated in the peri-infarcted area both by ES and lesion included genes of immunoglobulin heavy chain involved in B cells development which were knew to stroke and schizophrenia ([@B38]) but also genes involved in *Ataxia telangiectasia* \[immunoglobulin J polypeptide (IgJ)\] ([@B17]; [@B55]), Fc domain of Ig that binds to a cell surface receptor (Fcris) which is secreted by activated microglia in neurodegenerative diseases like Alzheimer' disease ([@B10]) as well as Ig kappa chain V--III region MOPC 6-like (LOC50284) involved in the Restless legs syndrome ([@B9]) ([Table 1](#T1){ref-type="table"}).

### Synergistic Downregulated Genes {#S3.SS3.SSS3}

Downregulated genes in the perilesional cortex as compared to the corresponding cortical area of the sham-operated aged rats, included genes like *dopamine receptor D1A* (*Drd1a*) involved in feeding behavior ([@B18]) and depression ([@B3]), *glutamate decarboxylase* (Gad1) and *solute carrier family 5 member D* (*Slc5d3*) involved in neuronal development ([@B35]), schizophrenia ([@B58]) and autophagy ([@B61]) as well as *ubiquitin specific peptidase 11* (*Usp11*)([Table 1](#T1){ref-type="table"}).

Transcripts encoding *adenosin A2a receptor* (*Adora2a*) and *ermin* (*Ermn*) have been associated with neurodegeneration ([@B56]), multiple sclerosis and epileptic seizures ([@B60]; [@B51]). Finally, transcript encoding *tachykinin precursor 1* (*Tac1*) has been involved in pain-related coping responses ([@B23]) while *phosphodiesterase 1B*, *calmodulin-dependent* (*Pde1b*) was associated with the process of learning and memory ([@B53]).

GO Enrichment Analysis: Genes Involved in Neuronal Development and Neuronal Growth Cone {#S3.SS4}
---------------------------------------------------------------------------------------

Among the significantly downregulated genes involved in growth cone and neuronal development, we noted: *Gja1*, *Sox2*, *Map2*, *Map1b*, *p35*, *Bcl11b*, *Tmod2*, *Drd1*, *Thy1*, *Gria3*, *Nedd4*, *Kif5c*, *Negr1*, *Syn2*. Only one, coding for the BDNF receptor (*Trkb*), was upregulated. Very large decreases were noted for *Gja1* (16-fold), *Sox2* (10-fold), and *Map2* (6-fold) ([Table 2](#T2){ref-type="table"}).

###### 

GO enrichment analysis: genes involved in neuronal development and neuronal growth cone.

  **Sequence code**   **Sequence name**   **Sequence description**                  **Fold change ECS vs. CTRL**   ***P*-value**
  ------------------- ------------------- ----------------------------------------- ------------------------------ ---------------
  1369640_at          Gja1                Gap junction protein, alpha 1             −16,6                          \<0,001
  1375153_at          Sox2                SRY-box transcription factor 2            −10,5                          \<0,001
  1368411_at          Map2                Microtubule associated protein 2          −6,6                           \<0,001
  1369538_at          Cdk5r1              Cyclin-dependent kinase 5 (p35)           −3,7                           0.006
  1391948_at          Bcl11b              BAF chromatin remodeling complex          −3,6                           \<0,001
  1369541_at          Tmod2               Tropomodulin 2                            −3,4                           \<0,001
  1368478_at          Drd1a               dopamine receptor D1A                     −3,2                           \<0,001
  1395357_at          Map1b               Microtubule associated protein 1b         −2,9                           \<0,001
  1369651_at          Thy1                Thy1 cell surface antigen                 −2,8                           \<0,001
  1368691_at          Gria3               Glutamate receptor, ionotrophic, AMPA 3   −2,3                           0.035
  1375119_at          Nedd4               NEDD4 E3 ubiquitin protein ligase         −2,3                           \<0,001
  1396154_at          Kif5c               Kinesin family member 5C                  −2,1                           \<0,001
  1387204_at          Negr1               Neuronal growth regulator 1               −2,0                           \<0,001
  1369482_at          Syn2                Synapsin II                               −2,0                           \<0,001
  1397246_at          Ntrk2               Trkb (BDNF receptor)                      2,0                            \<0,001

Electrical Stimulation Led to Increased Neurogenesis in the Infarct Core {#S3.SS5}
------------------------------------------------------------------------

To assess whether ES led to an increased number of newborn cells in the ischemic area, we performed a triple immunostaining using neuronal markers (NeuN, Tubulin beta III) and a marker of cell proliferation, Brdu ([@B33]) ([Figure 4](#F4){ref-type="fig"}). In control animals there were many co-localized NeuN/Tubulin beta III cells in the perilesional area ([Figure 4A](#F4){ref-type="fig"}, arrow). However, we could not detect co-localized BrdU/Tubulin beta III cells in the infarct core itself ([Figure 4B](#F4){ref-type="fig"}, arrowhead). Similarly, there was no clear colocalization of BrdU nuclei with Tubulin beta III in the perilesional area of ES animals ([Figure 4C](#F4){ref-type="fig"}). However, the number of BrdU-labeled Tubulin beta III cells in the infarct core of ES animals showed a significant 18-fold increase {*P* = 0.0001; \[*F*(DFn, DFd) = 9.611 (3,76)\]} by one-way ANOVA ([Figure 4E](#F4){ref-type="fig"}) over the perilesional area of controls ([Figure 4D](#F4){ref-type="fig"}, arrows).

![Electrical stimulation led to increased neurogenesis in the infarct core. In control animals there were many co-localized NeuN/Tubulin beta III cells in the perilesional area (**A**, arrow). However, we could not detect co-localized BrdU/Tubulin beta III cells in the infarct core itself (**B**, arrowhead). Similarly, there was no clear colocalization of BrdU nuclei with Tubulin beta III in the perilesional area of ES animals **(C)**. Noteworthy, the number of BrdU-labeled Tubulin beta III cells in the infarct core of ES animals showed a significant 18-fold increase over controls (**D**, arrows). **(E)** Number of co-localized TUB/BrdU cells in the infarct core. \*\*\**P* = 0.0001 by one-way ANOVA followed by Dunnett's multiple comparisons test. PI, peri-infarct; IC, infarct core.](fnins-14-00732-g004){#F4}

EC Stimulation Led to Increased Neurogenesis in the Hippocampus {#S3.SS6}
---------------------------------------------------------------

Next, we counted the numbers of the early neuronal marker doublecortin (DCX) by immunofluorescence in the hippocampus of aged rats after focal ischemia. In the ipsilateral hippocampi of ES rats we noted vigorous increase \[threefold; *P* = 0.0001; *F*(3,76) = 110.5\] by one-way ANOVA ([Figures 5A,E](#F5){ref-type="fig"}), over the ipsilateral side of controls ([Figure 5C](#F5){ref-type="fig"}). Of note, stroke injury did increase the number pf BrdU^+^ cells both in the contralateral ([Figure 5B](#F5){ref-type="fig"}) and the ipsilateral hippocampus of controls ([Figure 5D](#F5){ref-type="fig"}). However, in the contralateral side, the effect of stimulation on the number of DCX-positive cells, although significant, was less evident (1.8-fold; *P* = 0.001) by Dunnett's multiple comparison test ([Figure 5E](#F5){ref-type="fig"}).

![Electrical stimulation led to increased neurogenesis in the hippocampus. By double immunofluorescence, in the ipsilateral hippocampi of ES rats we noted vigorous (threefold) increase in the number of doublecortin cells **(A)** over the ipsilateral side of controls **(C)**. Stroke injury did increase the number pf BrdU^+^ cells both in the ipsilateral hippocampus **(D)** and the contralateral hippocampus **(B)** of controls. Of note, in the contralateral side, the effect of stimulation on the number of BrdU-positive nuclei was less evident (1.8-fold) **(E)**. \*\*\**P* = 0.0001 by one-way ANOVA followed by Dunnett's multiple comparisons test. ES, electrostimulation; ipsi, ipsilateral; CL, contralateral.](fnins-14-00732-g005){#F5}

EC Stimulation Led to Increased Neurogenesis in the Subventricular Zone {#S3.SS7}
-----------------------------------------------------------------------

Cerebral ischemia stimulates cell proliferation in the SVZ and multiply the number of migrating neurons which express DCX that into the nearby lesioned area ([@B4]; [@B39]). Given the time elapsed after the first and second stimulation and the time required for neuronal differentiation of DCX cells, we aimed to find out how many cells are still labeled with a BrdU nucleus at 48 days post-stroke. The analysis of the numbers of co-localized BrdU/DCX in the ipsilateral subventricular zone revealed a significant increase {ninefold; *P* = 0.0001; \[*F*(3, 76) = 110.5\]} by one-way ANOVA, in the number of BrdU/DCX+ cells in the ipsilateral hemisphere of ES animals ([Figure 6A](#F6){ref-type="fig"}) as compared with the contralateral hemisphere of the same animal ([Figures 6A](#F6){ref-type="fig"} vs. [6B](#F6){ref-type="fig"}) and [Figure 6E](#F6){ref-type="fig"}. In control animals, despite of large numbers of DCX and BrdU-positive cells, we could not detect clear co-localized BrdU/DCX cells both in the ipsilateral and contralateral hemisphere ([Figures 6C](#F6){ref-type="fig"} vs. [6D](#F6){ref-type="fig"}).

![Electrical stimulation led to increased neurogenesis in the subventricular zone. Analysis of the numbers of co-localized BrdU/DCX cells in the subventricular zone revealed a significant increase (18-fold in the number of BrdU/DCX+ cells in the ipsilateral hemisphere of ES animals) (**A**, and inset) as compared with the contralateral hemisphere of the same animals (**B**, and inset; **E**). In control animals, despite of large numbers of DCX and BrdU-positive cells, we could not detect clear co-localized BrdU/DCX cells both in the ipsilateral and contralateral hemisphere (**C** vs. **D**). \*\*\**P* = 0.0001 by one-way ANOVA followed by Dunnett's multiple comparisons test.](fnins-14-00732-g006){#F6}

Discussion {#S4}
==========

Despite remarkable advances in cell therapy for stroke, stem cell-based tissue replacement has not been achieved yet, stimulating the search for alternative strategies for brain self-repair using the neurogenic zones of the brain, the dentate gyrus and the subventricular zone ([@B34]). However, it is not clear whether increased neurogenesis improves neurobehavioral recovery or aids brain repair. In this study we report that electrical stimulation (ES) of post-stroke aged rats led to a considerable increase in the number of Tubulin beta III in the infarcted area and a robust increase in newly born DCX cells in the dentate gyrus and SVZ of the infarcted hemisphere. Behaviorally, ES had a beneficial effect on spatial long-term memory (T-maze) but not on the rotating pool or inclined plane, both tests requiring complex sensorimotor skills. However, ES had a detrimental effect on the asymmetric sensorimotor deficit.

Neural stem cells (NSCs) persist in the adult mammalian brain in two specific regions, the dentate gyrus of the hippocampus, and the subventricular zone ([@B47]) throughout life. The subventricular zone (SVZ) is involved in brain regeneration by continuously generating new neuronal precursors from embryonic radial glia cells ([@B20]). The human SVZ also acts as a neurogenic niche generating new neurons ([@B47]). Much like in rodents, in humans, SVZ-derived neuroblasts migrate via rostral migratory stream (RMS) into the olfactory bulb of infants ([@B22]).

In the adult brain, traumatic brain injury and ischemia greatly stimulate neurogenesis in the SVZ, generating calretinin-positive neurons in regions nearby SVZ/RMS such as the striatum ([@B25]; [@B32]). Similarly, the electroconvulsive therapy (ECT), a highly effective treatment of severe depression, may induce plastic changes in frontal limbic circuitry by stimulating neurogenesis in the hippocampus, dentate gyrus and subventricular zone ([@B14]; [@B24]). However, all ECT stimulus parameters should be considered explicitly in dosage since summary metrics like charge do not uniquely determine the stimulus and its physiological effects. In addition, ECT electrode configuration should be carefully considered. For example, brief-pulse bifrontotemporal ECT, although highly effective with a 70--80% response rate, it may result in significant cognitive side effects ([@B49], [@B50]; [@B30]; [@B42]).

The mechanisms underlying the beneficial effects of non-invasive brain electric stimulation are not fully understood. Numerous studies have revealed that brain stimulation of the ventromedial prefrontal cortex in middle aged rats, enhanced short-term memory in the novel-object recognition task ([@B31]), improved depressive behavior ([@B63]) and restored the number of neuronal precursors after spinal cord injury (SCI) ([@B8]). Likewise, transcranial direct current stimulation also stimulates neurogenesis in mice ([@B44]) and in a rat model of stroke along with oligodendrocyte precursors recruitment ([@B11]).

The abnormal brain electrical activity may result in a robust increase in the number of neuronal precursors in the adult dentate gyrus ([@B40]). In addition, in previous work we have shown that the time required for neuronal maturation after stimulating neurogenesis in the subventricular zone and hippocampus the brain is 24 days ([@B14]). For this reason, we applied the stimulus at 7- and 24 days after stroke. Using this time frame, we also avoided the fulminant inflammatory reaction to brain injury in aged brains ([@B45]).

ES-Specific Long-Term Down Regulation of Cortical Gene Expression After Stroke {#S4.SS1}
------------------------------------------------------------------------------

It is not clear how to corelate the changes in gene expression that would support the increased in neurogenesis and the beneficial effects on spatial long-term memory (T-maze). On one hand, there was an upregulation of several genes expressed in activated microglia in neurodegenerative diseases like Alzheimer' disease ([@B10]). Indeed, non-invasive brain electrical stimulation leads to microglia activation in brain slices tempting to speculate that M2 microglia might support plasticity relevant for neurorehabilitation and network re-organization in the diseased brain ([@B21]). On the other hand, there were genes that were unique to ES including *seizure related 6 homolog* like, one of the physiological substrate of the β-secretase BACE1 ([@B43]) and *Igfbp3* which has been shown to have a neuroprotective effect by modulating the bioavailability of insulin-like growth factor-I (IGF-I) ([@B36]). Furthermore, serum IGFBP3 could represent a biomarker for post-stroke outcome and functional recovery ([@B19]).

In the clinic, ECT is widely used for the treatment of major depression, as well as for treatment of catatonic schizophrenia and acute mania ([@B48]). Indeed, among the downregulated genes, we identified the gene coding for *dopamine receptor* D1A (*Drd1a*) involved in depression ([@B3]). Also downregulated were most of the genes involved in growth cone and neuronal development suggesting an additional mechanisms of the ETC treatment in schizophrenia patients.

Behaviorally, the aged rats could also have benefitted from the downregulation of genes involved in schizophrenia like solute carrier family 5member D (*Slc5d3*) ([@B58]), or transcripts encoding *adenosin A2a receptor* (Adora2a) and ermin (*Ermn*) have been associated with neurodegeneration ([@B56]), multiple sclerosis and epileptic seizures ([@B60]; [@B51]).

Conclusion {#S5}
==========

Electrical stimulation of post-stroke aged rats led to an improved functional recovery of spatial long-term memory but not on the rotating pool or inclined plane, both tests requiring complex sensorimotor skills. Surprisingly, ES had a detrimental effect on the asymmetric sensorimotor deficit. Histologically, there was a robust increase in the number of newly born DCX cells in the dentate gyrus and SVZ of the infarcted hemisphere and a considerable presence of neuronal marker, tubulin beta III in the infarcted area. ES was associated with a long-term down regulation of cortical gene expression after stroke and enhanced recuperation after cerebral ischemia in aged rats suggesting that gene expression in the peri-infarcted area may not be linked to electrical stimulation induced-neurogenesis in the subventricular zone and hippocampus.
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